Long-term Follow-up Study of Substance Abuse Screening and Intervention in Multi Primary Care Centers

Substance Use Clinical Trial

Official title:

Long-term Follow-up Study of Substance Abuse Screening and Intervention in Multi Primary Care Centers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03452241
• Other study ID #: JDu-004
• Status: Completed
• Phase: N/A
• Start date: April 14, 2018
• Est. completion date: March 10, 2020

Study information

• Verified date: March 2020
• Source: Shanghai Mental Health Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Description:

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit related medical staffs in five provinces to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 480
• Est. completion date: March 10, 2020
• Est. primary completion date: July 10, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• aged 18-75 years;

• the patient to the community medical institutions;

• ASSIST score is in 12-27, in a moderate risk;

• voluntary to participate;

• to agree to complete baseline interviews and follow-up studies

Exclusion Criteria:

• unable to complete the questionnaire;

• serious physical illness, action inconvenience.

Related Conditions & MeSH terms

• Substance Use
• Substance-Related Disorders

Intervention

Other:
• Intervention Group
The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.BI refers to a standard 15-30 minute intervention that includes a series of standard models that stimulate knowledge, motivation and behavior that reduce substance abuse.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.
• Control Group
The participants only receive the materials about the harm of substance use.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.

Locations

Country	Name	City	State
China	Henan Provincical Peoples Hospital	Henan

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai Mental Health Center

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline in risk behaviors at 1 and 3 month	Risk Behaviors will be measured by ASSIST questionnaire.	baseline, 1 and 3 month
Secondary	Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire	Knowledge related to substance use will be measured by Knowledge related to Addiction questionnaire	baseline, 1 and 3 month
Secondary	Motivation measured by Pre-treatment Readiness Scale	PRSS is a 5-point scale and the highest score at any stage represents the patient at this stage.	baseline, 1 and 3 month
Secondary	Depression measured by Self-Rating Depression Scale (SDS)	SDS contains 20 items and the standard total score is 53, 53-62: mild to mild depression; 63-72: moderate to severe;> 72: severe depression	baseline, 1 and 3 month
Secondary	Anxiety measured by Self-Rating Anxiety Scale (SAS).	SDS contains 20 items. According to the Chinese norm results, the standard points of the cut-off value is 50 points, of which 50-59 is divided into mild anxiety, 60-69 is divided into moderate anxiety, 70 points for severe anxiety	baseline, 1 and 3 month
Secondary	Self-esteem measured by Self-esteem questionnaire	the change of self-esteem will be measured by Self-esteem questionnaire.	baseline, 1 and 3 month
Secondary	Positive and Negative Affect measured by Positive and Negative Affect Scale (PANAS)	It contains 20 entries. A high positive emotional score indicates an individual's energy, concentration, and emotional well-being while a low score indicates indifference. Negative emotional high points that the individual subjective feeling puzzled, painful emotional state, while the score is low that calm.	baseline, 1 and 3 month